Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The impact of clinical stage on prostate cancer survival following radical prostatectomy.

Tollefson MK, Karnes RJ, Rangel LJ, Bergstralh EJ, Boorjian SA.

J Urol. 2013 May;189(5):1707-12. doi: 10.1016/j.juro.2012.11.065. Epub 2012 Nov 15.

PMID:
23159265
2.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

3.

The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.

Mikel Hubanks J, Boorjian SA, Frank I, Gettman MT, Houston Thompson R, Rangel LJ, Bergstralh EJ, Jeffrey Karnes R.

Urol Oncol. 2014 Jan;32(1):26.e1-7. doi: 10.1016/j.urolonc.2012.09.002. Epub 2013 Feb 6.

PMID:
23395235
4.

Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.

J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. Epub 2007 Aug 14.

PMID:
17698121
5.

Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.

Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.

BJU Int. 2011 Jun;107(11):1755-61. doi: 10.1111/j.1464-410X.2010.09730.x. Epub 2010 Oct 13.

6.

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.

J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. Epub 2007 Jul 16.

PMID:
17631342
7.

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.

Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT.

J Urol. 2005 Sep;174(3):903-7.

PMID:
16093984
8.

Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.

Freedland SJ, Presti JC Jr, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL; SEARCH Database Study Group..

J Urol. 2003 Jun;169(6):2129-35.

PMID:
12771734
9.
11.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651
12.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
13.
14.

Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.

Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA.

J Urol. 2006 Aug;176(2):564-8.

PMID:
16813890
15.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
16.

The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era.

Boorjian SA, Karnes RJ, Crispen PL, Carlson RE, Rangel LJ, Bergstralh EJ, Blute ML.

J Urol. 2010 Mar;183(3):1003-9. doi: 10.1016/j.juro.2009.11.039. Epub 2010 Jan 21.

PMID:
20092854
17.

Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.

Shikanov S, Song J, Royce C, Al-Ahmadie H, Zorn K, Steinberg G, Zagaja G, Shalhav A, Eggener S.

J Urol. 2009 Jul;182(1):139-44. doi: 10.1016/j.juro.2009.02.139. Epub 2009 May 17.

PMID:
19450829
18.

Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.

Yossepowitch O, Sircar K, Scardino PT, Ohori M, Kattan MW, Wheeler TM, Reuter VE.

J Urol. 2002 Nov;168(5):2011-5.

PMID:
12394697
19.

Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.

Tollefson MK, Boorjian SA, Gettman MT, Rangel LJ, Bergstralh EJ, Karnes RJ.

Urol Oncol. 2013 Nov;31(8):1483-8. doi: 10.1016/j.urolonc.2012.03.014. Epub 2012 May 10.

PMID:
22578510
20.

Supplemental Content

Support Center